Histamine may play role in colorectal tumorigenesis

September 20, 2017

(HealthDay)—Administration of histamine-producing gut microbes to histidine decarboxylase (HDC)-deficient mice reduces inflammation and tumor formation, suggesting an innovative approach to colorectal cancer (CRC) prevention and treatment, according to an experimental study published online Sept. 13 in The American Journal of Pathology.

Noting that HDC deficiency promotes inflammation-associated colorectal cancer, Chunxu Gao, Ph.D., from the Baylor College of Medicine in Houston, and colleagues examined the role of luminal histamine production in colon carcinogenesis.

The researchers found that administration of hdc+ Lactobacillus reuteri in the gut resulted in luminal hdc gene expression and production of histamine in the intestines of Hdc−/− mice. A decrease in the number and size of colon tumors was seen with this histamine-producing probiotic, as well as a decrease in colonic uptake of [18F]-fluorodeoxyglucose by in Hdc−/− mice. L. reuteri administration suppressed keratinocyte chemoattractant, interleukin (IL)-22, IL-6, tumor necrosis factor, and IL1α in the colonic mucosa, and reduced the amounts of proinflammatory keratinocyte chemoattractant, IL-22, and IL-6 in plasma. Relative numbers of splenic CD11b+Gr-1+ immature myeloid cells were also decreased by histamine-generating L. reuteri. An isogenic HDC-deficient L. reuteri mutant, which could not generate histamine, did not suppress carcinogenesis.

"Our results suggest a significant role for histamine in the suppression of chronic intestinal inflammation and colorectal tumorigenesis," James Versalovic, M.D., Ph.D., pathologist-in-chief at Texas Children's Hospital, said in a statement.

One author disclosed ties to BioGaia AB, which partially funded the study.

Explore further: New research on probiotics in the prevention and treatment of colon cancer

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

New research on probiotics in the prevention and treatment of colon cancer

September 13, 2017
In an innovative approach to colorectal cancer (CRC) prevention and treatment, scientists are studying ways to replace missing metabolites in patients prone to gut inflammation and CRC. A new study in The American Journal ...

Tourette-like tics vanish in mice treated with histamine

June 6, 2017
Yale scientists produced increased grooming behavior in mice that may model tics in Tourette syndrome and discovered these behaviors vanish when histamine—a neurotransmitter most commonly associated with allergies—is ...

Gut bacteria may hold key to treating autoimmune disease

December 19, 2016
Defects in the body's regulatory T cells (T reg cells) cause inflammation and autoimmune disease by altering the type of bacteria living in the gut, researchers from The University of Texas Health Science Center at Houston ...

Blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy

May 25, 2016
Simultaneous pre-treatment with antihistamines that block both the H1 and H4 antihistamine receptors suppressed the gastrointestinal symptoms of food allergy in mice, according to researchers at National Jewish Health. The ...

Mice fed tryptophan develop immune cells that foster a tolerant gut

August 3, 2017
Immune cells patrol the gut to ensure that harmful microbes hidden in the food we eat don't sneak into the body. Cells that are capable of triggering inflammation are balanced by cells that promote tolerance, protecting the ...

Exposure to common environmental bacteria may be source of some allergic inflammation

January 31, 2012
Could some cases of asthma actually be caused by an allergic reaction to a common environmental bacteria? New research findings published in the Journal of Leukocyte Biology suggests that this idea may not be as far-fetched ...

Recommended for you

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

New method uses just a drop of blood to monitor lung cancer treatment

October 17, 2018
Dr. Tasuku Honjo won the 2018 Nobel Prize in physiology or medicine for discovering the immune T-cell protein PD-1. This discovery led to a set of anti-cancer medications called checkpoint inhibitors, one of the first of ...

Gene screening technique helps identify genes involved in a fatty liver-associated liver cancer

October 17, 2018
With an estimated twenty-thousand protein-coding genes in the human genome, pinpointing a specific gene or pathway responsible for a particular disease can be like finding a needle in the proverbial haystack. This has certainly ...

Scientists zero in on ways to boost colorectal cancer screening

October 17, 2018
A comprehensive analysis by University of North Carolina Lineberger Comprehensive Cancer Center researchers evaluated more than 70 clinical studies to identify some of the most effective methods for boosting U.S. colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.